Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Cetilistat (ATL-962) is a novel inhibitor of pancreatic lipase being developed by Alizyme for the treatment of obesity and associated co-morbidities, including type 2 diabetes.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
100 mg | In stock | $ 37.00 | |
200 mg | In stock | $ 48.00 |
Description | Cetilistat (ATL-962) is a novel inhibitor of pancreatic lipase being developed by Alizyme for the treatment of obesity and associated co-morbidities, including type 2 diabetes. |
Targets&IC50 | Pancreatic lipase (human):5.95 nM, Pancreatic lipase (rat):54.8 nM |
Synonyms | ATL-962 |
Molecular Weight | 401.58 |
Formula | C25H39NO3 |
CAS No. | 282526-98-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: Insoluble
DMSO: Insoluble
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Cetilistat 282526-98-1 Metabolism Lipid high-fat diet cholesterol Inhibitor anti-obesity pancreatic lipase ATL-962 inhibit ATL 962 ATL962 inhibitor